Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells

[1]  P. Altevogt,et al.  The adhesion molecule L1 (CD171) promotes melanoma progression , 2006, International journal of cancer.

[2]  R. Häsler,et al.  Acquired chemoresistance in pancreatic carcinoma cells: induced secretion of IL-1β and NO lead to inactivation of caspases , 2006, Oncogene.

[3]  G. Sauter,et al.  L1 (CD171) is highly expressed in gastrointestinal stromal tumors , 2006, Modern Pathology.

[4]  P. Altevogt,et al.  Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment. , 2006, Cancer research.

[5]  J. Izbicki,et al.  L1 is a potential marker for poorly-differentiated pancreatic neuroendocrine carcinoma. , 2006, World journal of gastroenterology.

[6]  C. Blobel,et al.  L1 Is Sequentially Processed by Two Differently Activated Metalloproteases and Presenilin/γ-Secretase and Regulates Neural Cell Adhesion, Cell Migration, and Neurite Outgrowth , 2005, Molecular and Cellular Biology.

[7]  P. Altevogt,et al.  L1 augments cell migration and tumor growth but not β3 integrin expression in ovarian carcinomas , 2005, International journal of cancer.

[8]  O. Stoeltzing,et al.  Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells , 2005, British Journal of Cancer.

[9]  R. Schmid,et al.  Pancreatic cancer: basic and clinical aspects. , 2005, Gastroenterology.

[10]  J. Berlin,et al.  Treatment for pancreatic cancer: current therapy and continued progress. , 2005, Gastroenterology.

[11]  Melitta Schachner,et al.  Signal transduction pathways implicated in neural recognition molecule L1 triggered neuroprotection and neuritogenesis , 2005, Journal of neurochemistry.

[12]  P. Altevogt,et al.  L1, a novel target of β-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers , 2005, The Journal of cell biology.

[13]  B. Sipos,et al.  Tumor Stroma Interactions Induce Chemoresistance in Pancreatic Ductal Carcinoma Cells Involving Increased Secretion and Paracrine Effects of Nitric Oxide and Interleukin-1β , 2004, Cancer Research.

[14]  M. Korc,et al.  Aberrant Expression of Neuropilin-1 and -2 in Human Pancreatic Cancer Cells , 2004, Clinical Cancer Research.

[15]  K. Tsuchida,et al.  Tumor-Stroma Interaction of Human Pancreatic Cancer: Acquired Resistance to Anticancer Drugs and Proliferation Regulation Is Dependent on Extracellular Matrix Proteins , 2004, Pancreas.

[16]  P. Altevogt,et al.  L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas , 2003, The Lancet.

[17]  S. Kenwrick,et al.  Cis and trans interactions of L1 with neuropilin‐1 control axonal responses to semaphorin 3A , 2002, The EMBO journal.

[18]  A. Arlt,et al.  Autocrine Production of Interleukin 1β Confers Constitutive Nuclear Factor κB Activity and Chemoresistance in Pancreatic Carcinoma Cell Lines , 2002 .

[19]  P. Altevogt,et al.  Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins , 2001, The Journal of cell biology.

[20]  H. Kalthoff,et al.  Inhibition of NF-κB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin , 2001, Oncogene.

[21]  M. Hortsch.  Structural and Functional Evolution of the L1 Family: Are Four Adhesion Molecules Better Than One? , 2000, Molecular and Cellular Neuroscience.

[22]  A. Arlt,et al.  The putative apoptosis inhibitor IEX-1L is a mutant nonspliced variant of p22(PRG1/IEX-1) and is not expressed in vivo. , 1999, Biochemical and biophysical research communications.

[23]  S. Kenwrick,et al.  Neural cell recognition molecule L1: from cell biology to human hereditary brain malformations , 1998, Current Opinion in Neurobiology.

[24]  R. Kerbel,et al.  Cell adhesion and drug resistance in cancer , 1997, Current opinion in oncology.

[25]  M. Schachner.  Neural recognition molecules and synaptic plasticity. , 1997, Current opinion in cell biology.

[26]  T. Ohnishi,et al.  Gene expression of neural cell adhesion molecule L1 in malignant gliomas and biological significance of L1 in glioma invasion. , 1996, Cancer research.

[27]  G. Lauer,et al.  p53 and K-RAS alterations in pancreatic epithelial cell lesions. , 1993, Oncogene.

[28]  D. Teplow,et al.  Neural adhesion molecule L1 as a member of the immunoglobulin superfamily with binding domains similar to fibronectin , 1988, Nature.

[29]  A. Arlt,et al.  Autocrine production of interleukin 1beta confers constitutive nuclear factor kappaB activity and chemoresistance in pancreatic carcinoma cell lines. , 2002, Cancer research.